Seroprevalence of SARS-CoV-2 in Niger State: A Pilot Cross Sectional Study
Author:
Majiya HussainiORCID, Aliyu-Paiko Mohammed, Balogu Vincent Tochukwu, Musa Dickson Achimugu, Salihu Ibrahim Maikudi, Kawu Abdullahi Abubakar, Bashir Ishaq Yakubu, Sani Aishat Rabiu, Baba John, Muhammad Amina Tako, Jibril Fatima Ladidi, Bala Ezekiel, Obaje Nuhu George, Aliyu Yahaya Badeggi, Muhammad Ramatu Gogo, Mohammed Hadiza, Gimba Usman Naji, Uthman Abduljaleel, Liman Hadiza Muhammad, Alhaji Sule Alfa, James Joseph Kolo, Makusidi Muhammad Muhammad, Isah Mohammed Danasabe, Abdullahi Ibrahim, Ndagi Umar, Waziri Bala, Bisallah Chindo Ibrahim, Dadi-Mamud Naomi John, Ibrahim Kolo, Adamu Abu Kasim
Abstract
Background: Coronavirus Disease 2019 (COVID-19) Pandemic caused by SARS-CoV-2 is ongoing causing human and socioeconomic losses.
Objective: To know how far the virus has spread in Niger State, Nigeria, a pilot study was carried out to determine the SARS-CoV-2 seroprevalence, patterns, dynamics, and risk factors in the state.
Methods: A cross sectional study design and Clustered-Stratified-Random sampling strategy were used to select 185 test participants across the state. SARS-CoV-2 IgG and IgM Rapid Test Kits (Colloidal gold immunochromatography lateral flow system) were used to determine the presence or absence of the antibodies to the virus in the blood of sampled participants across Niger State as from 26th June 2020 to 30th June 2020. The test kits were validated using the blood samples of some of the Nigeria Center for Disease Control (NCDC) confirmed positive and negative COVID-19 cases in the State. SARS-CoV-2 IgG and IgM Test results were entered into the EPIINFO questionnaire administered simultaneously with each test. EPIINFO was then used for to calculate arithmetic mean and percentage, odd ratio, chi-square, and regression at 95% Confidence Interval of the data generated.
Results: The seroprevalence of SARS-CoV-2 in Niger State was found to be 25.41% and 2.16% for the positive IgG and IgM respectively. Seroprevalence among age groups, gender and by occupation varied widely. COVID-19 asymptomatic rate in the state was found to be 46.81%. The risk analyses showed that the chances of infection are almost the same for both urban and rural dwellers in the state. However, health care workers, those that experienced flu-like symptoms and those that have had contact with person (s) that travelled out of Nigeria in the last six (6) months (February -June 2020) are twice ( 2 times) at risk of being infected with the virus. More than half (54.59%) of the participants in this study did not practice social distancing at any time since the pandemic started. Discussions about knowledge, practice and attitude of the participants are included.
Conclusion: The observed Niger State SARS-CoV-2 seroprevalence and infection patterns means that the virus is widely spread, far more SARS CoV-2 infections occurred than the reported cases and high asymptomatic COVID-19 across the state.
Publisher
Cold Spring Harbor Laboratory
Reference15 articles.
1. Baud, D. , Qi, X. , Nielsen-Saines, K. , Musso, D. , Pomar, L. , & Favre, G. (2020). Real estimates of mortality following COVID-19 infection. The Lancet infectious diseases. 2. Countrymeters. (2020). Nigeria population (2020) live — Countrymeters. Retrieved 14 July 2020, from https://countrymeters.info/en/Nigeria 3. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village 4. Lai, C. C. , Shih, T. P. , Ko, W. C. , Tang, H. J. , & Hsueh, P. R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges. International journal of antimicrobial agents, 105924. 5. Majiya, H. (2020). Some control measures may lead to more transmissions. Retrieved 14 July 2020, from https://www.dailytrust.com.ng/some-control-measures-may-lead-to-more-transmissions.html
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|